Top compounds associated with response to EGFR


Feature Type Standardized
Nominal ANOVA
mRNA Cetuximab GDSC1000 pan-cancer AAC 0.36 7e-19
mRNA Erlotinib CTRPv2 pan-cancer AAC 0.3 3e-16
mRNA Gefitinib GDSC1000 pan-cancer AAC 0.32 1e-15
mRNA Erlotinib gCSI pan-cancer AAC 0.53 4e-13
mRNA Erlotinib CCLE pan-cancer AAC 0.42 2e-12
mRNA Gefitinib CTRPv2 pan-cancer AAC 0.25 5e-11
mRNA canertinib CTRPv2 pan-cancer AAC 0.24 3e-10
mRNA BIBW2992 CTRPv2 pan-cancer AAC 0.23 4e-09
mRNA Panobinostat CCLE pan-cancer AAC -0.3 3e-08
mRNA Vandetanib CTRPv2 pan-cancer AAC 0.21 3e-08
Download CSV